Healing, Equity, Advocacy and Respect for Mamas

NCT ID: NCT06273436

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

2894 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-28

Study Completion Date

2030-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the study is to learn if a program for newborn mom's can improve detection of complications after delivery and help women get medical care quickly and easily. Participants will be asked to complete a survey at the time of enrollment and at 3 additional times. All surveys can be completed via cell-phone or email. All women will be followed for 1-year after delivery. Women that enroll will be assigned to one of two groups: usual in person care OR usual in-person care PLUS a text message-based program that will ask about sign and symptoms of complications that may occur after delivery. If there is a concern, a nurse advocate will call on the phone to discuss options and help refer to care if needed. Participants will be paid for their time in completing surveys.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

AIM (AIM Alliance for Innovation on Maternal Health) safety bundles delivered in-person

Group Type NO_INTERVENTION

No interventions assigned to this group

Usual Care plus H.E.A.R. for Mamas

H.E.A.R. for Mamas is designed to provide the AIM (Alliance for Innovation on Maternal Health) Postpartum Discharge Transition education systematically and to frequently monitor women for signs and symptoms of postpartum complications using simple, patient-centered technology (text/phone).

Group Type EXPERIMENTAL

H.E.A.R. for Mamas

Intervention Type OTHER

H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

H.E.A.R. for Mamas

H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina.
* Aged 16-49 years old.
* Insured by Medicaid.


\- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit.

Exclusion Criteria

* Plans to relocate outside of SC anytime during the postpartum year.
* Plans to discontinue Medicaid health insurance during the postpartum year.
* Speaks a language other than English or Spanish.
* Incarcerated/pending incarceration during peripartum period.
* Currently institutionalized.
* Enrolled in current MUSC study funded by PCORI (#Pro00123833)
* Does not have and/or does not wish to use their personal cell phone for the study.


* Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from.
* Unable or unwilling to commit to completing surveys or an interview.
* Speaking a language other than English.
Minimum Eligible Age

16 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Patient-Centered Outcomes Research Institute

OTHER

Sponsor Role collaborator

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Constance Guille

Professor - Faculty

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Constance Guille, MD

Role: CONTACT

843-792-6489

Ellen H Gomez, MA

Role: CONTACT

8439985635

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Constance Guille, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00130902

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Navigating New Motherhood 2
NCT03922334 COMPLETED NA
Reshaping Postpartum Follow-up
NCT06054841 COMPLETED NA
Maternal Mental Health Access - MaMa
NCT06049433 RECRUITING NA